Jason Paragas

Jason is a technology executive with a long track record of success in the life sciences industry. In addition to serving as CEO of DVLP, he is the founder and president of a company that is using artificial intelligence, synthetic biology, and immunology to create the next breakthrough vaccine platform after mRNA. 

Prior to this, Jason served as VP of Valo Health, where he sourced technology, data, and partnerships for a leading AI drug discovery company. He also spent 20 years with the NIAID, DOD, DOE, and Lawrence Livermore National Laboratory, where he led projects that solved national and health security challenges with advanced technology and innovative public-private partnerships. 

Jason serves on several boards and is a sought-after advisor to new companies.